U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
162601162601Acoustic Startle Reduction In Cocaine DependenceActive, not recruitingNo Results AvailableCocaine-Related DisordersProcedure: acoustic startle testinghttps://ClinicalTrials.gov/show/NCT00430690
162602162602Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedHas ResultsSystemic Lupus ErythematosusDrug: Corticosteroids (prednisone or prednisolone)|Drug: Abatacept|Drug: Abatacept|Drug: Mycophenolate mofetil (MMF)|Drug: Abatacepthttps://ClinicalTrials.gov/show/NCT00430677
162603162603A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for PleurodesisRecruitingNo Results AvailableMalignant Pleural Effusions|Recurrent Pleural Effusions|Primary Spontaneous Pneumothorax|Secondary Spontaneous PneumothoraxProcedure: Pleurodesis with either talc or iodopovidonehttps://ClinicalTrials.gov/show/NCT00430664
162604162604Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)CompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Docetaxel|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00430651
162605162605A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II HypertensionCompletedHas ResultsHypertensionDrug: olmesartan medoxomil + hydrochlorothiazide, if necessary|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00430638
162606162606A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher DiseaseCompletedHas ResultsGaucher Disease, Type 1Biological: VPRIV ®,https://ClinicalTrials.gov/show/NCT00430625
162607162607The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)Active, not recruitingNo Results AvailableMyocardial Infarctionhttps://ClinicalTrials.gov/show/NCT00430612
162608162608The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT00430599
162609162609Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown LinesCompletedNo Results AvailableGlabellar Frown LinesDrug: Botulinum neurotoxin type A, free of complexing proteins|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00430586
162610162610Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance UseCompletedNo Results AvailableSubstance-Related DisordersDrug: D-cycloserine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00430573
162611162611Work Activity Augmented by Cognitive Rehabilitation for SchizophreniaActive, not recruitingNo Results AvailableSchizophrenia|Schizoaffective DisorderBehavioral: cognitive rehabilitation|Procedure: work therapy|Behavioral: work therapyhttps://ClinicalTrials.gov/show/NCT00430560
162612162612Thyroid-Associated Ophthalmopathy Subtypes and Orbital AntibodiesCompletedNo Results AvailableGraves' OphthalmopathyDrug: Carbimazole, radio-active iodine (I131)https://ClinicalTrials.gov/show/NCT00430547
162613162613Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).CompletedNo Results AvailableEpstein Barr Virus (EBV) InfectionBiological: EBV vaccine (268664)https://ClinicalTrials.gov/show/NCT00430534
162614162614Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)CompletedNo Results AvailablePandemic FluBiological: Pandemic influenza vaccine (GSK1119711A)-formulation 1|Biological: Pandemic influenza vaccine (GSK1119711A)-formulation 2https://ClinicalTrials.gov/show/NCT00430521
162615162615Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedHas ResultsEssential HypertensionDrug: olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo|Drug: olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets|Drug: olmesartan medoxomil/hydrochlorothiazide tablets|Drug: olmesartan medoxomil/hydrochlorothiazide tabletshttps://ClinicalTrials.gov/show/NCT00430508
162616162616A Phase II Dose-finding Study of Atacicept in Rheumatoid Arthritis (RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: Atacicepthttps://ClinicalTrials.gov/show/NCT00430495
162617162617Stress, Distress Intolerance, and Drug DependenceCompletedNo Results AvailableSubstance DependenceBehavioral: Cognitive Behavioral Therapy|Behavioral: Individual Counselinghttps://ClinicalTrials.gov/show/NCT00430482
162618162618Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT RecipientsWithdrawnNo Results AvailableFungal Infection|Bacterial InfectionDrug: human lactoferrin (hLF1-11)https://ClinicalTrials.gov/show/NCT00430469
162619162619Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.CompletedNo Results AvailableStrokeProcedure: Exercisehttps://ClinicalTrials.gov/show/NCT00430456
162620162620Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AMLTerminatedNo Results AvailableAcute Lymphocytic Leukemia|Acute Myelogenous LeukemiaDrug: Liposomal Annamycinhttps://ClinicalTrials.gov/show/NCT00430443
162621162621Lipoprotein Turnover on Low- and High-MUFA Portfolio DietsActive, not recruitingNo Results AvailableHyperlipidemia|Cardiovascular Diseases|Diet TherapyProcedure: High MUFA dietary portfolio|Procedure: Low MUFA dietary portfoliohttps://ClinicalTrials.gov/show/NCT00430430
162622162622Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation StudyCompletedNo Results AvailableBone Diseases, Endocrinehttps://ClinicalTrials.gov/show/NCT00430417
162623162623Screening and Treatment of Depression in the CommunityCompletedNo Results AvailableDepressionOther: Collaborative care (Intervention)https://ClinicalTrials.gov/show/NCT00430404
162624162624Comparison of Video Consent Versus Routine Consent for Participation in Research StudiesCompletedNo Results AvailableSchizophreniaOther: DVD Consent|Other: Routine Controlhttps://ClinicalTrials.gov/show/NCT00430391
162625162625Acupuncture for Prevention of Radiation-Induced XerostomiaActive, not recruitingNo Results AvailableXerostomia|Mouth Dryness|Nasopharyngeal CancerProcedure: Acupuncture|Other: Standard Carehttps://ClinicalTrials.gov/show/NCT00430378
162626162626Maintenance Therapy Using Lenalidomide in MyelomaActive, not recruitingNo Results AvailableMyelomaDrug: lenalidomide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00430365
162627162627MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.CompletedHas ResultsNon-Hodgkin's LymphomaDrug: rituximab [MabThera/Rituxan]https://ClinicalTrials.gov/show/NCT00430352
162628162628Juvista (Avotermin) in Scars Following Varicose Vein RemovalCompletedNo Results AvailableVaricose Veins|CicatrixDrug: Avoterminhttps://ClinicalTrials.gov/show/NCT00430326
162629162629Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or OxaliplatinActive, not recruitingNo Results AvailableLiver Cancer|Liver MetastasisProcedure: Electro-Stimulation of Yongquan (K1) Acupoint|Procedure: Electro-Stimulation of Yongquan (K1) Acupointhttps://ClinicalTrials.gov/show/NCT00430313
162630162630Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.TerminatedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: UK-432,097|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00430300

* Görseller ve İçerik tekif hakkına sahip olabilir